Early Alert: Infusion Set Performance Issue from BD
FDA Authorizes Marketing of First Eyeglass Lenses to Slow Progression of Pediatric Myopia
FDA Authorizes Marketing of First Eyeglass Lenses to Slow Progression of Pediatric Myopia
http://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-eyeglass-lenses-slow-progression-pediatric-myopia
FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib)
FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib)
http://www.fda.gov/news-events/press-announcements/fda-removes-risk-evaluation-and-mitigation-strategies-rems-caprelsa-vandetanib
Blood and Plasma Warming Device Correction: 3M Company Issues Correction for Ranger Blood/Fluid Warming System
Early Alert: Automated Impella Controller Purge Retainer Fixation Issue from Abiomed
FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy
FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy
http://www.fda.gov/news-events/press-announcements/fda-responds-evidence-possible-association-between-autism-and-acetaminophen-use-during-pregnancy
FDA Takes Action to Make a Treatment Available for Autism Symptoms
FDA Takes Action to Make a Treatment Available for Autism Symptoms
http://www.fda.gov/news-events/press-announcements/fda-takes-action-make-treatment-available-autism-symptoms
Olympus Issues Voluntary Recall for Specific Lots of ViziShot 2 FLEX (19G) EBUS -TBNA Needles
FDA Grants Accelerated Approval to First Treatment for Barth Syndrome
FDA Grants Accelerated Approval to First Treatment for Barth Syndrome
http://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-first-treatment-barth-syndrome